References
- World Health Organization. WHO report on the tuberculosis epidermic. Publ. No. WHO/TB/95. Geneva: World Health Organization; 1995. p. 183
- Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin Immunol 2004;110:2-12 https://doi.org/10.1016/S1521-6616(03)00210-9
- Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129 https://doi.org/10.1146/annurev.immunol.19.1.93
- Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004;84:93-101 https://doi.org/10.1016/j.tube.2003.08.010
- Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54 https://doi.org/10.1084/jem.178.6.2249
- Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561-72 https://doi.org/10.1016/1074-7613(95)90001-2
- Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995;63:736-40
- Pathan AA, Wilkinson KA, Wilkinson RJ, Latif M, McShane H, Pasvol G, et al. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur J Immunol 2000;30: 2713-21 https://doi.org/10.1002/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4
- Smith SM, Brookes R, Klein MR, Malin AS, Lukey PT, King AS, et al. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000;165:7088-95
- Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH, et al. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998;187:1633-40 https://doi.org/10.1084/jem.187.10.1633
- Lewinsohn DM, Zhu L, Madison VJ, Dillon DC, Fling SP, Reed SG, et al. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuber culosis-infected cells: definition of antigenic specificity. J Immunol 2001;166:439-46
- van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-98 https://doi.org/10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4
- Tully G, Kortsik C, Hohn H, Zehbe I, Hitzler WE, Neukirch C, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 2005;174:2174-84
- Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol 1999;162:372-9
- Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A 2000;97:12210-5
- Cho JE, Lee KW, Park SK, Cheon SH, Cho SN, Cho S. The study of MHC calss I restricted CD8+ T cell mediated immune responses against Mycobacterium tuberculosis infection: evidence of M. tuberculosis specific CD8+ T cells in TB patients and PPD+ healthy individuals. Immune Netw 2003;3:235-41
- Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994;153:5586-92
- del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995;154:685-93
- Hurely C. Sequence-based typing for HLA-A. In: Tilanus MG, Hansen JA, Hurley CK, editors. Calss I sequencing amplification of exons 2 and 3 based upon Cereb. IHWG Technical Manual. Vol. TM7A. Seatle: International Histocompatibility Working Group; 2000
- Murray PJ. Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol 1999;7:366-72 https://doi.org/10.1016/S0966-842X(99)01567-X
- Flynn JL. Why is IFN-gamma insufficient to control tuberculosis? Trends Microbiol 1999;7:477-8
- Chen A, Wang L, Zhang J, Zou L, Jia Z, Zhou W, et al. H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity. J Virol 2005;79:5568-76 https://doi.org/10.1128/JVI.79.9.5568-5576.2005
- Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 2003;198:693-704 https://doi.org/10.1084/jem.20030846